C07D 309/04
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D309/04 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 642 US grants and 595 published applications in this corpus.
Search patents in C07D- Granted patents
- 642
- Published applications
- 595
- Assignees
- 370
- Inventors
- 2,328
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 5 | 0 |
| 1978 | 23 | 0 |
| 1979 | 4 | 0 |
| 1980 | 9 | 0 |
| 1981 | 17 | 0 |
| 1982 | 11 | 0 |
| 1983 | 6 | 0 |
| 1984 | 8 | 0 |
| 1985 | 4 | 0 |
| 1986 | 9 | 0 |
| 1987 | 4 | 0 |
| 1988 | 6 | 0 |
| 1989 | 9 | 0 |
| 1990 | 8 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 10 | 0 |
| 1994 | 11 | 0 |
| 1995 | 16 | 0 |
| 1996 | 15 | 0 |
| 1997 | 14 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 4 | 0 |
| 2001 | 8 | 1 |
| 2002 | 11 | 8 |
| 2003 | 10 | 13 |
| 2004 | 7 | 14 |
| 2005 | 4 | 19 |
| 2006 | 5 | 19 |
| 2007 | 12 | 19 |
| 2008 | 9 | 18 |
| 2009 | 13 | 32 |
| 2010 | 18 | 22 |
| 2011 | 10 | 19 |
| 2012 | 18 | 33 |
| 2013 | 27 | 27 |
| 2014 | 26 | 30 |
| 2015 | 30 | 45 |
| 2016 | 37 | 45 |
| 2017 | 31 | 35 |
| 2018 | 24 | 24 |
| 2019 | 26 | 20 |
| 2020 | 22 | 22 |
| 2021 | 16 | 20 |
| 2022 | 12 | 23 |
| 2023 | 11 | 32 |
| 2024 | 11 | 13 |
| 2025 | 8 | 27 |
| 2026 | 12 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Processes for preparing modulators of alpha-1 antitrypsin7 Jul 2026US 12,673,952 B2Vertex Pharmaceuticals Incorporated
- Chemical compounds and uses thereof23 Jun 2026US 12,662,451 B2Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Bulky and small-steric-hindrance ligand and use thereof17 Sep 2026US 2026/0273518 A1Dg Hc Optical Co., Ltd
- Novel compound, and pharmaceutical composition comprising same as active ingredient10 Sep 2026US 2026/0265189 A1Sapiensbio Inc.
- Method for producing very-long-chain polyunsaturated fatty acid27 Aug 2026US 2026/0250228 A1Nissui Corporation
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Lipid compounds, compositions, and uses thereof20 Aug 2026US 2026/0242346 A1Liberate Bio, Inc.
Most cited
By later US patents
- Anticonvulsant sulfamate derivatives134US 4,513,006 AMcNeil Lab, Inc. · 1985
- Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity80US 5,489,584 AAllergan, Inc. · 1996
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009
- Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity76US 5,543,534 AAllergan, Inc. · 1996
- Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases71US 8,563,735 B2AbbVie Inc. · 2013